JP Stock MarketDetailed Quotes

4519 Chugai Pharmaceutical

Watchlist
  • 5648.0
  • -68.0-1.19%
20min DelayNot Open Jul 1 15:00 JST
9.29TMarket Cap28.55P/E (Static)

Chugai Pharmaceutical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-24.11%236.95B
-11.78%1.11T
-37.56%273.81B
14.48%257.9B
13.50%267.42B
-13.35%312.24B
26.00%1.26T
36.07%438.5B
-21.58%225.28B
6.41%235.61B
Cost of revenue
-51.79%72.95B
-13.22%413.31B
-56.76%92.06B
13.26%78.26B
14.83%91.66B
32.25%151.33B
40.84%476.25B
92.58%212.91B
-33.69%69.1B
17.29%79.82B
Gross profit
1.92%164B
-10.90%698.06B
-19.43%181.75B
15.02%179.64B
12.82%175.76B
-34.57%160.91B
18.42%783.48B
6.55%225.59B
-14.68%156.19B
1.59%155.79B
Operating expense
2.41%64.13B
3.49%258.89B
-20.94%60.18B
23.02%72.96B
13.06%63.14B
6.30%62.62B
4.36%250.17B
4.77%76.11B
-2.65%59.3B
-1.40%55.85B
Selling and administrative expenses
7.47%22.59B
12.05%112.58B
0.02%30.76B
15.82%27.54B
43.65%33.26B
-7.77%21.02B
-1.89%100.48B
-11.73%30.75B
-3.77%23.78B
0.34%23.16B
-Selling and marketing expense
7.47%22.59B
12.05%112.58B
0.02%30.76B
15.82%27.54B
43.65%33.26B
-7.77%21.02B
31.18%100.48B
26.32%30.75B
28.83%23.78B
29.26%23.16B
Research and development costs
-3.53%41.36B
16.87%174.87B
-7.46%41.86B
24.15%45.57B
31.79%44.57B
26.58%42.87B
8.98%149.63B
19.64%45.23B
1.40%36.71B
0.76%33.82B
Other operating expenses
114.59%185M
-44,726.56%-28.56B
-9,817.97%-12.44B
86.53%-160M
-1,203.82%-14.69B
-156.36%-1.27B
--64M
--128M
---1.19B
---1.13B
Operating profit
1.60%99.87B
-17.65%439.17B
-18.66%121.58B
10.11%106.69B
12.68%112.62B
-47.44%98.3B
26.41%533.31B
7.49%149.47B
-20.69%96.89B
3.34%99.94B
Net non-operating interest income (expenses)
-98.90%15M
51,733.33%4.65B
311.79%1.11B
142.48%788M
78.53%1.38B
-14.63%1.37B
-132.14%-9M
40.30%-526M
-667.28%-1.86B
150.16%773M
Non-operating interest income
-98.90%15M
----
----
----
76.27%1.39B
-15.24%1.37B
----
----
----
--788M
Non-operating interest expense
----
-55.74%27M
-50.00%8M
-53.33%7M
-40.00%9M
-85.71%2M
27.08%61M
33.33%16M
25.00%15M
25.00%15M
Total other finance cost
----
-8,888.46%-4.67B
-320.00%-1.12B
-143.21%-795M
----
----
31.58%-52M
-41.31%510M
642.77%1.84B
----
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses)
15.98%-2.13B
3.09%267M
Income before tax
0.23%99.89B
-16.44%443.82B
-17.78%122.69B
13.09%107.48B
13.19%113.99B
-46.48%99.66B
26.65%531.17B
7.78%149.22B
-20.60%95.03B
3.81%100.71B
Income tax
-2.57%25.49B
-24.49%118.35B
-32.64%31.48B
9.80%29.9B
8.70%30.8B
-51.94%26.16B
34.67%156.74B
18.03%46.74B
-19.12%27.24B
7.78%28.34B
Net income
1.23%74.4B
-13.08%325.47B
-11.00%91.21B
14.42%77.57B
14.94%83.19B
-44.22%73.5B
23.58%374.43B
3.68%102.48B
-21.18%67.8B
2.34%72.38B
Net income continuous operations
1.23%74.4B
-13.08%325.47B
-11.00%91.21B
14.42%77.57B
14.94%83.19B
-44.22%73.5B
23.58%374.43B
3.68%102.48B
-21.18%67.8B
2.34%72.38B
Noncontrolling interests
Net income attributable to the company
1.23%74.4B
-13.08%325.47B
-11.00%91.21B
14.42%77.57B
14.94%83.19B
-44.22%73.5B
23.58%374.43B
3.68%102.48B
-21.18%67.8B
2.34%72.38B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
1.23%74.4B
-13.08%325.47B
-11.00%91.21B
14.42%77.57B
14.94%83.19B
-44.22%73.5B
23.58%374.43B
3.68%102.48B
-21.18%67.8B
2.34%72.38B
Gross dividend payment
Basic earnings per share
1.21%45.22
-13.10%197.83
-11.01%55.43
14.41%47.15
14.93%50.57
-44.25%44.68
23.52%227.64
3.61%62.29
-21.22%41.21
2.28%44
Diluted earnings per share
1.21%45.21
-13.08%197.8
-11.00%55.43
14.42%47.14
14.94%50.56
-44.23%44.67
23.57%227.57
3.66%62.28
-21.19%41.2
2.33%43.99
Dividend per share
0
2.56%80
0.00%40
0
5.26%40
0
2.63%78
-13.04%40
0
26.67%38
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -24.11%236.95B-11.78%1.11T-37.56%273.81B14.48%257.9B13.50%267.42B-13.35%312.24B26.00%1.26T36.07%438.5B-21.58%225.28B6.41%235.61B
Cost of revenue -51.79%72.95B-13.22%413.31B-56.76%92.06B13.26%78.26B14.83%91.66B32.25%151.33B40.84%476.25B92.58%212.91B-33.69%69.1B17.29%79.82B
Gross profit 1.92%164B-10.90%698.06B-19.43%181.75B15.02%179.64B12.82%175.76B-34.57%160.91B18.42%783.48B6.55%225.59B-14.68%156.19B1.59%155.79B
Operating expense 2.41%64.13B3.49%258.89B-20.94%60.18B23.02%72.96B13.06%63.14B6.30%62.62B4.36%250.17B4.77%76.11B-2.65%59.3B-1.40%55.85B
Selling and administrative expenses 7.47%22.59B12.05%112.58B0.02%30.76B15.82%27.54B43.65%33.26B-7.77%21.02B-1.89%100.48B-11.73%30.75B-3.77%23.78B0.34%23.16B
-Selling and marketing expense 7.47%22.59B12.05%112.58B0.02%30.76B15.82%27.54B43.65%33.26B-7.77%21.02B31.18%100.48B26.32%30.75B28.83%23.78B29.26%23.16B
Research and development costs -3.53%41.36B16.87%174.87B-7.46%41.86B24.15%45.57B31.79%44.57B26.58%42.87B8.98%149.63B19.64%45.23B1.40%36.71B0.76%33.82B
Other operating expenses 114.59%185M-44,726.56%-28.56B-9,817.97%-12.44B86.53%-160M-1,203.82%-14.69B-156.36%-1.27B--64M--128M---1.19B---1.13B
Operating profit 1.60%99.87B-17.65%439.17B-18.66%121.58B10.11%106.69B12.68%112.62B-47.44%98.3B26.41%533.31B7.49%149.47B-20.69%96.89B3.34%99.94B
Net non-operating interest income (expenses) -98.90%15M51,733.33%4.65B311.79%1.11B142.48%788M78.53%1.38B-14.63%1.37B-132.14%-9M40.30%-526M-667.28%-1.86B150.16%773M
Non-operating interest income -98.90%15M------------76.27%1.39B-15.24%1.37B--------------788M
Non-operating interest expense -----55.74%27M-50.00%8M-53.33%7M-40.00%9M-85.71%2M27.08%61M33.33%16M25.00%15M25.00%15M
Total other finance cost -----8,888.46%-4.67B-320.00%-1.12B-143.21%-795M--------31.58%-52M-41.31%510M642.77%1.84B----
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses) 15.98%-2.13B3.09%267M
Income before tax 0.23%99.89B-16.44%443.82B-17.78%122.69B13.09%107.48B13.19%113.99B-46.48%99.66B26.65%531.17B7.78%149.22B-20.60%95.03B3.81%100.71B
Income tax -2.57%25.49B-24.49%118.35B-32.64%31.48B9.80%29.9B8.70%30.8B-51.94%26.16B34.67%156.74B18.03%46.74B-19.12%27.24B7.78%28.34B
Net income 1.23%74.4B-13.08%325.47B-11.00%91.21B14.42%77.57B14.94%83.19B-44.22%73.5B23.58%374.43B3.68%102.48B-21.18%67.8B2.34%72.38B
Net income continuous operations 1.23%74.4B-13.08%325.47B-11.00%91.21B14.42%77.57B14.94%83.19B-44.22%73.5B23.58%374.43B3.68%102.48B-21.18%67.8B2.34%72.38B
Noncontrolling interests
Net income attributable to the company 1.23%74.4B-13.08%325.47B-11.00%91.21B14.42%77.57B14.94%83.19B-44.22%73.5B23.58%374.43B3.68%102.48B-21.18%67.8B2.34%72.38B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 1.23%74.4B-13.08%325.47B-11.00%91.21B14.42%77.57B14.94%83.19B-44.22%73.5B23.58%374.43B3.68%102.48B-21.18%67.8B2.34%72.38B
Gross dividend payment
Basic earnings per share 1.21%45.22-13.10%197.83-11.01%55.4314.41%47.1514.93%50.57-44.25%44.6823.52%227.643.61%62.29-21.22%41.212.28%44
Diluted earnings per share 1.21%45.21-13.08%197.8-11.00%55.4314.42%47.1414.94%50.56-44.23%44.6723.57%227.573.66%62.28-21.19%41.22.33%43.99
Dividend per share 02.56%800.00%4005.26%4002.63%78-13.04%40026.67%38
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
JP
Overall
Symbol
Latest Price
%Chg